Dr. Judith Phillips Sill, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 45121 Ukiah Street, Suite G, Mendocino, CA 95460 Phone: 707-937-3000 Fax: 707-937-3373 |
News Archive
Tension while waiting for test results, the fear of not making it, the feeling of being under pressure, apprehension: these emotional states often come with physical illnesses like backache, headache, nausea, tachycardia, tremors, difficulty breathing, dizziness.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
Inviragen, a biotechnology company developing vaccines to protect against infectious diseases worldwide, announced today that it has received two grants totaling $488,958 through the United States government's Qualifying Therapeutic Discovery Project Program.
An NOP survey, released today by Cancer Research UK's Race for Life, reveals that only three per cent of those surveyed know that people who are overweight are more likely to develop cancer than people of normal weight, while 70 per cent are aware of the link with heart disease.
Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox® (onabotulinumtoxinA) could be an effective treatment for the disease.
› Verified 6 days ago